Handel nachbörslich: 39.00

Cg Oncology Inc (CGON)

Cg Oncology Inc Aktie (CGON) Neueste Nachrichten

Cg Oncology Inc (CGON)

Cg Oncology Inc Aktie (CGON) Neueste Nachrichten

Selling Buzz: Cg Oncology Inc. [CGON] Director Song Hong Fang sells 650,455 shares of the company - Knox Daily

Wilson Sonsini Advises GC Therapeutics on $65 Million Series A - Wilson Sonsini

Waterloo Capital L.P. Purchases 1,517 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World

Corning’s stock rises as it sticks to Q3 profit view - MarketWatch

Compugen Ltd. (NASDAQ:CGEN) Short Interest Update - Defense World

CGN Resources Ltd. Options Cease Amid Unmet Conditions - TipRanks

Cognyte Software (NASDAQ:CGNT) Lifted to “Strong-Buy” at StockNews.com - Defense World

Canadian General Investments (TSE:CGI) Share Price Passes Above 50 Day Moving Average of $38.48 - MarketBeat

Why is the Cochlear share price in the red today? - The Motley Fool Australia

Calamos Global Total Return Fund (NASDAQ:CGO) Short Interest Update - Defense World

Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.1% - Defense World

Adversity is less terrifying than hope: Cg Oncology Inc. (CGON) - SETE News

(CGO) Pivots Trading Plans and Risk Controls - Stock Traders Daily

GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long - Business Wire

Compugen Ltd. (NASDAQ:CGEN) Short Interest Down 5.8% in August - MarketBeat

Coherus shares stumble on supply issue - The Pharma Letter

Quest Partners LLC Acquires New Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

HC Wainwright Reiterates Buy Rating for CG Oncology (NASDAQ:CGON) - MarketBeat

Analyst supports Buy rating on CG Oncology shares, focusing on differentiated safety profile - Investing.com Canada

CG Oncology, Inc. (NASDAQ:CGON) Short Interest Down 11.2% in August - MarketBeat

After-hours movers: Intuitive Machines, Casella Waste Systems, Galmed Pharma, Edgewise Therapeutics - Investing.com South Africa

Do investors need to be concerned about Cg Oncology Inc. (CGON)? - US Post News

Cogent Biosciences Inc (COGT) stock analysis: A comprehensive overview - US Post News

Coherus Biosciences Inc (CHRS) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Coherus BioSciences, Inc. (NASDAQ:CHRS) Has Found A Path To Profitability - Simply Wall St

The battle brewing over blood tests for cancer | Today News - Mint

Cg Oncology Inc. (CGON) Stock: A Comprehensive 52-Week Review - The InvestChronicle

The Battle Brewing Over Blood Tests for Cancer - The Wall Street Journal

Analyzing Cg Oncology Inc. (CGON) After Recent Trading Activity - Knox Daily

CG Oncology (NASDAQ:CGON) Trading 4.6% Higher - MarketBeat

CG Oncology surges 7%; seen benefitting from J&J bladder cancer asset data - MSN

CG Oncology, Inc. (NASDAQ:CGON) Shares Acquired by Bank of New York Mellon Corp - MarketBeat

CG Oncology surges 7%; seen benefitting from J&J bladder cancer asset data - Seeking Alpha

Is Cogent Biosciences Inc (COGT) positioned for future growth? - SETE News

Quarterly Metrics: Quick and Current Ratios for Cogent Biosciences Inc (COGT) - The Dwinnex

Stock Market Recap: Cg Oncology Inc. (CGON) Concludes at 34.80, a -0.09 Surge/Decline - The Dwinnex

CG Oncology shares: Goldman Sachs reiterates Buy, cites limited downside amid new data - Investing.com Canada

Cg Oncology Inc. (CGON): Short Seller Sentiment is Bearish on This Cancer Stock - Insider Monkey

Cg Oncology Inc. (CGON): Short Seller Sentiment is Bearish on This Cancer Stock - Yahoo Finance

TD Asset Management Inc Purchases Shares of 93,084 CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat

A company insider recently sold 650,455 shares of Cg Oncology Inc. [CGON]. Should You Sale? - Knox Daily

Cg Oncology Inc. (CGON)’s results reveal risk - US Post News

CG Oncology (NASDAQ:CGON) Stock Price Down 3.6% - MarketBeat

10 Worst Cancer Stocks To Buy Now According to Short Sellers - Insider Monkey

Market Highlights: Cg Oncology Inc. (CGON) Ends on a Low Note at 36.12 - The Dwinnex

CGON: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle

Cg Oncology Inc. [CGON] Stock sold by Insider Song Hong Fang for $23.0 million - Knox Daily

Perhaps timely catching Cg Oncology Inc. (CGON) would be a good idea - SETE News

Cg Oncology Inc. [CGON] stock for 23,000,089 USD was sold by Song Hong Fang - Knox Daily

There is no doubt that Cg Oncology Inc. (CGON) ticks all the boxes. - SETE News

CG Oncology, Inc. (NASDAQ:CGON) Director Sells $23,000,088.80 in Stock - MarketBeat

CG Oncology director sells over $23 million in company stock By Investing.com - Investing.com Canada

Analysts Offer Predictions for CG Oncology, Inc.'s Q3 2024 Earnings (NASDAQ:CGON) - MarketBeat

Cg Oncology Inc. (CGON) Stock: A Year of Declines and Increases - The InvestChronicle

Cg Oncology Inc. (NASDAQ: CGON): Overvalued In Comparison To Others? - Stocks Register

CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - StockTitan

Roth starts CG Oncology at buy, cites anticipated FDA filing - MSN

CG Oncology (NASDAQ:CGON) Sees Strong Trading Volume - MarketBeat

CG Oncology (NASDAQ:CGON) Lifted to Strong-Buy at Roth Capital - MarketBeat

CG Oncology Insiders Added US$5.06m Of Stock To Their Holdings - Simply Wall St

Roth starts CG Oncology at buy, cites anticipated FDA filing (NASDAQ:CGON) - Seeking Alpha

CG Oncology (NASDAQ:CGON) Coverage Initiated by Analysts at Roth Mkm - Defense World

CG Oncology gains Buy rating, $65 target from Roth/MKM By Investing.com - Investing.com Canada

CG Oncology (NASDAQ:CGON) Now Covered by Analysts at Roth Mkm - MarketBeat

CG Oncology: Promising Data, But Looks Expensive (NASDAQ:CGON) - Seeking Alpha

Bullish CG Oncology Insiders Loaded Up On US$5.06m Of Stock - Yahoo Finance

CG Oncology, Inc. (NASDAQ:CGON) Short Interest Update - MarketBeat

Brokers Issue Forecasts for CG Oncology, Inc.'s Q1 2025 Earnings (NASDAQ:CGON) - MarketBeat

CG Oncology, Inc. Expected to Earn Q1 2025 Earnings of ($0.46) Per Share (NASDAQ:CGON) - Defense World

CG Oncology (NASDAQ:CGON) Releases Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat

CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates - StockTitan

CG Oncology : Reports Second Quarter 2024 Financial Results and Provides Business Updates Form 8 K - Marketscreener.com

Ähnlich wie CGON